MAK-System

MAK-System is a leading global provider of medical software for the management of blood, plasma, tissue, and cell and gene therapies. The company offers a comprehensive suite of end-to-end solutions that manage the entire lifecycle of biological products, from donor recruitment and collection to processing, testing, and final transfusion or transplantation. Its flagship e-Delphyn platform is widely utilized by national blood services, hospitals, and plasma centers to ensure regulatory compliance and operational efficiency. In 2024, the company was acquired by Haemonetics to strengthen its digital health portfolio and expand its presence in the cellular therapy market.